A structured treatment plan can provide additional support while helping patients stay focused on sustainable goals
Many patients describe the feeling as finally having an 'off switch' for hunger they never had before, which creates the metabolic conditions for sustainable weight loss without constant dietary vigilance
Yes, semaglutide is generally considered safer than bariatric surgery because it does not involve invasive procedures or surgical risks
Key Efficacy Comparison Year 1 Outcomes: For chronic weight management in adults without diabetes, tirzepatide 15 mg achieved a mean 22.5% total body weight reduction in SURMOUNT-1 (N Engl J Med, 2022), while semaglutide 2.4 mg delivered approximately 15% in the STEP program
Additionally, 32% of patients on resmetirom vs
Dosing, Titration, and Why Conversion Charts Can Mislead Both medicines use gradual dose escalation to improve tolerability